Company handles distribution of 'niche' blood, chemotherapy and specialty products
BDI Pharma (Columbia, SC) is in the final stages of construction and licensing of a DC near the Dallas-Fort Worth airport, the better to serve its customers of immunoglobulin, albumin, vaccines, chemotherapy products and other specialty pharmaceuticals. The facility, the company’s second national DC, more than doubles its warehousing capacity and ultimately will manage 40% of its shipments, according to a company statement. There is also room for future expansion.
BDI Pharma provides basic wholesaling services as well as sales and marketing services for manufacturers and reimbursement services for patients, seeking to act as a commercialization extension of its biopharma suppliers.
Earlier this year, it expanded its cold-chain storage capacity and built new offices near its Columbia, SC headquarters; at that time it announced a 40% increase in sales over the previous year.
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access
July 11th 2025New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem from encounter-level care barriers, such as limited access to rapid tests and telehealth, which emphasizes the need for systemic and practice-level reforms.